Individualizing Dual Antiplatelet Therapy After Percutaneous Coronary Intervention - The IDEAL-PCI Registry
Status:
Completed
Trial end date:
2013-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the efficacy and safety of a routine individualized
antiplatelet therapy after coronary stent implantation by evaluating "on-treatment" platelet
reactivity with Multiple Electrode Aggregometry (MEA, Multiplate® Analyzer).